Iveda Solutions gets 180-day Nasdaq bid-price extension to Sept 23, 2024

Iveda Solutions, Inc.

Nasdaq extended compliance period to September 23, 2024 for minimum $1.00 bid price.
Company must achieve $1.00 closing bid for 10 consecutive days or consider reverse stock split.
If not cured by Sept 23, 2024, Nasdaq will delist; company may appeal to Hearings Panel.
Extension granted because Iveda meets all other continued listing requirements except bid price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.